MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Medtech’s titans vied for their seats on the Top 5, shuffling the hierarchy everywhere but the top. Medtronic (NYSE:MDT) easily maintained its position at #1 with a slew of releases from conferences in the U.S and overseas, as well as some major developments in the long-running TAVI war with Edwards Lifesciences (NYSE:EW).
Covidien (NYSE:COV) generated a lot of internet chatter in May, taking the 2nd-place spot as subsidiary Given Imaging landed a victory with the FDA for its ingestible PillCam.
Boston Scientific (NYSE:BSX) jumped up to 3rd-place with a raft of news of its own, including the $415 million acquisition of Bayer AG’s interventional unit and several high-profile reports from Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions.
St. Jude Medical (NYSE:STJ) issued several high-profile reports of its own during the HRS conference, and generated further buzz with news of a new Justice Dept. probe. Johnson & Johnson (NYSE:JNJ) rejoined the Top 5 this month with news of its coming pipeline of 30 "major" medical device regulatory submissions through 2016.
Medtronic
- Medtronic slips ‘death penalty’ sanctions in pain pump death suit
- Medtronic settles kickbacks case for $10M
- Medtech gets a nod in Minnesota’s Super Bowl pitch
- Medtronic slips ‘death penalty’ sanctions in pain pump death suit
- Solicitor General objects to Medtronic’s high court bid
- Medtronic CEO: I’d do Ardian, CoreValve acquisitions all over again
- Medtronic to pay $150M for wearable sensor maker Corventis
- Medtronic lands E.U. approval for NC Euphora coronary balloon
- Edwards settlement slashes Medtronic’s Q4 profits
- Medtronic, Edwards ink $750M heart valve settlement
- Inspire Medical raises $40M on launch of new sleep apnea implant
- Negligence claims stand in Medtronic Infuse lawsuits
- Medtronic takes tiny heart monitor to Canada
- Medtronic taps GE Healthcare exec to lead diabetes unit
- HRS2014 wrap-up: Medtronic delays ICD therapy, Boston Scientific watches patients from afar, and more
- Jury: Medtronic owes bone cement acquisition $15M
- Battery wars at HRS2014: And the winner is?
- Medtronic cardiac rhythm implants fail 1st in head-to-head studies of longevity, researchers say
- Medtronic exec: Google looms large as next great rival
- Medtronic inks $22M deal to settle 950 Infuse lawsuits
- Medtronic spinout Inspire Medical lands FDA win for 1st sleep apnea implant
- Medtronic wins E.U. approval for adaptive, diagnostic Viva pacemaker
Covidien
- Confirmed: Covidien acquires Zephyr’s wearable monitors
- Device makers take big writedowns on renal denervation
- FDA downgrades Given Imaging’s PillCam
Boston Scientific
- Is Boston Scientific’s peripherals buy bad news for Cardiovascular Systems?
- Boston Scientific bolsters peripheral business with $415M Bayer buy
- Device makers take big writedowns on renal denervation
- Boston Scientific’s spinal stim targets pain relief with 3D anatomic modeling
- Medtronic delays ICD therapy, Boston Scientific watches patients from afar, and more
- Battery wars at HRS2014: And the winner is?
- CareFusion taps Boston Scientific exec Bose for board
- Boston Scientific discloses HHS probe into Cognis, Teligen ICDs
- Boston Scientific’s S-ICD strong at 22 months, promising in post-ICD patients
- Boston Scientific’s S-ICD causes few complications
- Boston Scientific nabs the rest of IoGyn for $65M
- Boston Scientific seeks heart failure innovation in partnership with Optum Labs
- Boston Scientific launches Promus Premier stent in Japan
St. Jude Medical
- New tax hasn’t hurt medtech R&D
- St. Jude touts EnligHTN data amid renal denervation backlash
- TAVI: St. Jude implants 1st patients in U.S. Portico study
- Device makers take big writedowns on renal denervation
- Perforations, deaths temporarily derail St. Jude’s E.U. Nanostim study
- St. Jude Medical and the ghost of product recall past
- Justice Dept. probes St. Jude for potential False Claims, kickbacks violations
- Battery wars at HRS2014: And the winner is?
- St. Jude’s lead-free Nanostim pacemaker still looks good at 1 year
- Remote heart failure monitoring can cut mortality in half, but why?
- St. Jude’s quadripolar pacing wins in 1st head-to-head study
- Justice Dept. probes St. Jude for potential False Claims, kickbacks violations
- St. Jude Medical’s patent review bid denied in FFR war with Volcano
Johnson & Johnson
- China fines J&J and other contact lens makers for anti-trust violations
- J&J’s Synthes wins another round against Globus, ex-sales rep
- J&J’s pipeline includes 30 ‘major’ medical devices and a surgical robot
- Diabetes improvements remain 3 years after bariatric surgery, Ethicon reports
- Johnson & Johnson commits to $2.5B DePuy ASR settlement deal
- J&J’s Conor MedSystems can’t slip $100M Biotronik lawsuit
- Animals in labs: PETA’s long history with the medtech industry
- Judge slaps sanction on J&J’s lawyers in Ethicon pelvic mesh case
- Hologic taps J&J vet McMahon as new CFO
- FDA morcellator warning spurs lawsuit against J&J
